Literature DB >> 16980957

Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1.

Jinqiu Zhang1, Wai-Leong Tam, Guo Qing Tong, Qiang Wu, Hsiao-Yun Chan, Boon-Seng Soh, Yuefei Lou, Jianchang Yang, Yupo Ma, Li Chai, Huck-Hui Ng, Thomas Lufkin, Paul Robson, Bing Lim.   

Abstract

Embryonic stem (ES) cells are pluripotent cells that can self-renew or differentiate into many cell types. A unique network of transcription factors and signalling molecules are essential for maintaining this capability. Here, we report that a spalt family member, Sall4, is required for the pluripotency of ES cells. Similarly to Oct4, a reduction in Sall4 levels in mouse ES cells results in respecification, under the appropriate culture conditions, of ES cells to the trophoblast lineage. Sall4 regulates transcription of Pou5f1 which encodes Oct4. Sall4 binds to the highly conserved regulatory region of the Pou5f1 distal enhancer and activates Pou5f1 expression in vivo and in vitro. Microinjection of Sall4 small interfering (si) RNA into mouse zygotes resulted in reduction of Sall4 and Oct4 mRNAs in preimplantation embryos and significant expansion of Cdx2 expression into the inner cell mass. These results demonstrate that Sall4 is a transcriptional activator of Pou5f1 and has a critical role in the maintenance of ES cell pluripotency by modulating Oct4 expression. The data also indicates that Sall4 is important for early embryonic cell-fate decisions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16980957     DOI: 10.1038/ncb1481

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  242 in total

1.  The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis.

Authors:  Li Chai
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  Phosphatase and tensin homolog regulates the pluripotent state and lineage fate choice in human embryonic stem cells.

Authors:  Jackelyn A Alva; Grace E Lee; Erika E Escobar; April D Pyle
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

3.  Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.

Authors:  Hannes Hahne; Amin Moghaddas Gholami; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2012-06-01       Impact factor: 5.911

4.  Dicer is a key player in oocyte maturation.

Authors:  Hung-Ching Liu; YaXu Tang; Zhiying He; Zev Rosenwaks
Journal:  J Assist Reprod Genet       Date:  2010-09-09       Impact factor: 3.412

5.  Differential roles of Sall4 isoforms in embryonic stem cell pluripotency.

Authors:  Sridhar Rao; Shao Zhen; Sergei Roumiantsev; Lindsay T McDonald; Guo-Cheng Yuan; Stuart H Orkin
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

Review 6.  The placenta: transcriptional, epigenetic, and physiological integration during development.

Authors:  Emin Maltepe; Anna I Bakardjiev; Susan J Fisher
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

Review 7.  Interactome of a cardiopoietic precursor.

Authors:  Randolph S Faustino; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2008-06-03       Impact factor: 4.132

Review 8.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 9.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

10.  SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases.

Authors:  Markku Miettinen; Zengfeng Wang; Peter A McCue; Maarit Sarlomo-Rikala; Janusz Rys; Wojciech Biernat; Jerzy Lasota; Yi-Shan Lee
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.